Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s share price was up 18.4% on Monday . The company traded as high as GBX 1.80 ($0.02) and last traded at GBX 1.80 ($0.02). Approximately 1,461,598 shares changed hands during mid-day trading, an increase of 19% from the average daily volume of 1,225,284 shares. The stock had previously closed at GBX 1.52 ($0.02).
Cizzle Biotechnology Trading Down 2.4 %
The company has a market capitalization of £6.35 million, a PE ratio of -2,246.72 and a beta of 0.38. The stock has a fifty day simple moving average of GBX 1.77 and a 200-day simple moving average of GBX 1.85.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Recommended Stories
- Five stocks we like better than Cizzle Biotechnology
- What is the Dogs of the Dow Strategy? Overview and Examples
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- P/E Ratio Calculation: How to Assess Stocks
- NVIDIA Insiders Sell: This Is What It Means for the Market
- High Flyers: 3 Natural Gas Stocks for March 2022
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
